Dr. Ed Park of Recharge Biomedical explains how exosomes are made and validated. Dr. Duncan Ross helps explain data that the Kimera Labs team found suggesting large variance in exosome purity and potency between brands.
Dr. Ed Park of Recharge Biomedical explains face blindness, or prosopagnosia, which affects about one in fifty people. A case of significant improvement after exosome treatment is presented. (n.b. Exosomes are not FDA-approved to treat face blindness)